|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 479.12 USD | +0.59% |
|
-3.95% | +5.60% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 30.98x | 5.45x | 8.21x | 18.51x | 19.41x | 121B | ||
| 0.59% | 0.65% | 34.25x | 20.52x | 12.25x | 25.43x | 26.37x | 1,028B | ||
| 2.1% | 2.21% | 27.09x | 6.81x | 6.22x | 16.9x | 18.68x | 611B | ||
| 2.81% | 2.96% | 30.33x | 4444.08x | 7.27x | 14.9x | 15.39x | 432B | ||
| 3.06% | 3.14% | 17.47x | 6.47x | 4.34x | 10.68x | 12.01x | 323B | ||
| 2.9% | 3% | 21.17x | 6.32x | 5.44x | 13.17x | 14.4x | 277B | ||
| 2.02% | 2.13% | 20.69x | 4.85x | 4.37x | 12.08x | 13.04x | 257B | ||
| 3.55% | 3.45% | 13.99x | 6.19x | 5.26x | 10.84x | 12.65x | 217B | ||
| 2.84% | 3% | 23.3x | 17.92x | 6.19x | 10.94x | 14.17x | 192B | ||
| 2.5% | 2.59% | -46.85x | 8.21x | 5.61x | 31x | 61.84x | 161B | ||
| 7.12% | 7.19% | 12.32x | 1.57x | 3.04x | 7.69x | 8.67x | 138B | ||
| 4.42% | 4.5% | 11.06x | 5x | 3.07x | 8.27x | 8.9x | 116B | ||
| 5.63% | 5.97% | 11.39x | 1.21x | 2.14x | 6.85x | 7.8x | 104B | ||
| 3.63% | 3.82% | 12.16x | 4.43x | 2.71x | 7.82x | 8.97x | 103B | ||
| 1.89% | 2.17% | 23.42x | 5.31x | 7.93x | 14.99x | 15.68x | 73.58B | ||
| 0.46% | 1.28% | 21.23x | 1.72x | 1.76x | 8.34x | 14x | 55.22B | ||
| 0.49% | 0.55% | 39.26x | 5.29x | 8.88x | 29.38x | 30.45x | 53.42B | ||
| 3.84% | 3.91% | 43.31x | 1.15x | 2.66x | 9.77x | 27.05x | 51.97B | ||
| 2.22% | 2.47% | 18.6x | 1.88x | 3.39x | 12.73x | 14.28x | 42.52B | ||
| -.--% | -.--% | 37.23x | 17.66x | 6.19x | 28.11x | 27.24x | 37.55B | ||
| Average | 2.6% | 2.75% | 20.12x | 228.60x | 5.35x | 14.92x | 18.55x | 219.71B | |
| Weighted average by Cap. | 2.29% | 2.39% | 22.81x | 446.50x | 7.00x | 16.74x | 19.28x |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















